CMR Surgical
CMR Surgical raises $200M Series D at $3B valuation
Quick Facts
CMR Surgical: Series D Funding Round
CMR Surgical has successfully raised $200M in Series D funding, reaching a valuation of $3B.
Company Overview
Surgical robotic systems
Funding Details
The Series D round was led by SoftBank Vision Fund, with participation from LGT.
Company Information
- Headquarters: Cambridge, UK
- Founded: 2014
- Employees: 600+
- Category: MedTech
Investment
CMR Surgical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- SoftBank Vision Fund: Verified investor in Series D
- LGT: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
MedTech Revolution Secures $890M Series D to Lead MedTech Innovation
MedTech Revolution raises $890M in Series D funding at $13.7B valuation to complete clinical trials for 5 medical devices, scale robotic surgery systems, and expand to asian markets.
ForSight Robotics raises $125M Series B at $700M valuation
ForSight Robotics raises $125M in Series B at $700M valuation. Ophthalmic surgical robots...